Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post GTI Energy July 28, 2025 Related Posts Lahontan Announces Private Placement March 14, 2026 Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 14, 2026 Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario March 14, 2026
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 14, 2026
Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario March 14, 2026